Search results for " press"

showing 10 items of 4213 documents

Bone status in adolescents with type 1 diabetes

2010

Aims The aim of the study was to investigate the potential negative impact of type 1 diabetes on bone status of adolescents. Bone status in adolescents with type 1 diabetes was assessed by means of quantitative ultrasound (QUS) and the influence of metabolic control and other diseaserelated and growth variables was analysed. Methods Group I consisted of 99 pubertal (Tanner ≥2) adolescents (49 female), aged 14.3±2.5 years, diabetes duration 4.6±2.3 years. Controls (group II) were 297 children, matched by sex and age, from a healthy population. The influence of glycated haemoglobin (current: HbA1cD; last year’s mean: HbA1cY; whole duration mean: HbA1cT), diabetes duration, percentage of life …

Blood GlucoseMalemedicine.medical_specialtyHbA1cAdolescentEndocrinology Diabetes and Metabolismmedicine.medical_treatmentDiseaseBone and BonesStatistics NonparametricSurveys and QuestionnairesDiabetes mellitusInternal medicineImmunopathologyInternal MedicineHumansMedicineChildChromatography High Pressure LiquidUltrasonographyGlycated HemoglobinAnalysis of VarianceType 1 diabetesbusiness.industryPatient SelectionInsulinPubertymedicine.diseaseAdolescenceQuantitative ultrasoundDiabetes Mellitus Type 1EndocrinologyType 1 diabetesMetabolic control analysisFemaleAnalysis of variancebusinessQuantitative ultrasoundDiabetologia
researchProduct

Protective action of 1,3-butanediol in cerebral ischemia. A neurologic, histologic, and metabolic study.

1987

1,3-Butanediol (BD) is converted in the body to β-hydroxybutyrate, and previous studies have shown that hyperketonemia had beneficial effects in experimental models of generalized hypoxia. The aim of this study was to determine if BD would reduce brain damage following cerebral ischemia. A transient forebrain ischemia of 30-min duration was induced by the four-vessel occlusion technique in control and BD-treated rats (25 mmol/kg, i.p.; 30 min prior to ischemia). BD treatment led to significant improvement of neurologic deficit during the 72-h recovery period and reduced neuronal damage in the striatum and cortex but not in the CA1 sector of the hippocampus. Evaluation of cerebral energy me…

Blood GlucoseMalemedicine.medical_specialtyIschemiaHydroxybutyratesBlood PressureBrain damageHippocampusPhosphocreatinechemistry.chemical_compoundInternal medicinemedicine13-ButanediolAnimalsEnergy chargeButylene GlycolsCerebral CortexNeurons3-Hydroxybutyric Acidbusiness.industryBrainHypoxia (medical)medicine.diseaseCorpus StriatumRatsEndocrinologyNeurologychemistryIschemic Attack TransientLactic acidosisKetone bodiesNeurology (clinical)medicine.symptomCardiology and Cardiovascular MedicinebusinessEnergy MetabolismJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
researchProduct

Fasting prior to transient cerebral ischemia reduces delayed neuronal necrosis.

1990

A transient brain ischemia of 30-min duration was induced by the four-vessel occlusion technique in normally fed and in 48-hr-fasted rats. Evaluation of brain damage 72 hr after ischemia showed that fasting reduced neuronal necrosis in the striatum, the neocortex, and the lateral part of the CA1 sector of hippocampus. Signs of status spongiosis in the pars reticulata of the substantia nigra were seen in 75% of fed rats and in only 19% of fasted rats. The protective effect was associated with reduction in mortality and in postischemic seizure incidence. The metabolic changes induced by fasting were evaluated before and during ischemia. After 30 min of four-vessel occlusion, fasted rats showe…

Blood GlucoseMalemedicine.medical_specialtyIschemiaHydroxybutyratesSubstantia nigraBlood PressureBrain damageBiochemistryBrain ischemiaCellular and Molecular Neurosciencechemistry.chemical_compoundNecrosisReference ValuesInternal medicinemedicineAnimalsNeuronsGlycogen3-Hydroxybutyric Acidbusiness.industryAdenine NucleotidesBrainRats Inbred StrainsFastingmedicine.diseaseRatsEndocrinologyGlucosechemistryIschemic Attack TransientOrgan SpecificityLactic acidosisAnesthesiaKetone bodiesLactatesNeurology (clinical)medicine.symptomPars reticulatabusinessEnergy MetabolismMetabolic brain disease
researchProduct

Serum ionized magnesium in diabetic older persons

2014

Objective. Several alterations of magnesium metabolism have been associated with type 2 diabetes pathophysiology, a condition particularly frequent in older persons. We aimed to evaluate serum total (Mg-tot) and serum ionized magnesium (Mg-ion) in older persons with type 2 diabetes in order to explore clinically applicable methods for the detection of magnesium deficit. Material/Methods: Mg-tot and Mg-ion were measured in 105 fasting subjects with type 2 diabetes (mean age: 71.10.8 years; M/F: 45/60) and in 100 age-matched non-diabetic control persons (mean age: 72.20.8 years; M/F: 42/58). Results: Mg-ion concentrations were significantly lower in diabetic persons compared with controls (…

Blood GlucoseMalemedicine.medical_specialtySettore MED/09 - Medicina InternaEndocrinology Diabetes and Metabolismchemistry.chemical_elementType 2 diabetesEnd stage renal diseaseMagnesium Ionized magnesium Diabetes Hypertension AgingEndocrinologyDiabetes mellitusInternal medicinemedicineHumansMagnesiumAgedSubclinical infectionGlycated HemoglobinChemistryMagnesiummedicine.diseasePathophysiologyBlood pressureEndocrinologyDiabetes Mellitus Type 2Case-Control StudiesFemaleBody mass indexMetabolism
researchProduct

Protein oxidation in a group of subjects with metabolic syndrome.

2013

Abstract Aims To examine the protein oxidation, marker of the oxidative stress, in metabolic syndrome (MS). Methods We enrolled 106 subjects (45 women and 61 men) with MS of which 43 (14 women and 27 men) were with diabetes mellitus and 63 (31 women and 32 men) were without diabetes mellitus, and 54 subjects (19 women and 35 men) as control group. The protein oxidation, expressed as carbonyl groups, was measured by an enzyme-like immunosorbent assay (ELISA) kit (BioCell PC test kit, Enzo Life Sciences AG, Switzerland). Results In the whole group of MS subjects, in comparison with control group, a significant increase in carbonyl groups was present. The same datum was also evident between co…

Blood GlucoseMalemedicine.medical_specialtyWaistEndocrinology Diabetes and MetabolismIndiaBlood PressureProtein oxidationmedicine.disease_causeNitric OxideProtein CarbonylationInternal medicineDiabetes mellitusinsulin resistanceInternal MedicinemedicineHumansInflammationMetabolic Syndromeoxidative strebusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseOxidative StressEndocrinologyBlood pressureDiabetes Mellitus Type 2FemaleMetabolic syndromeWaist CircumferencebusinessOxidation-ReductionOxidative stressBiomarkersDiabetesmetabolic syndrome
researchProduct

Associations of cardiometabolic risk factors with heart rate variability in 6‐ to 8‐year‐old children: The PANIC Study

2019

BACKGROUND Associations of cardiometabolic risk factors with heart rate variability (HRV) in children are unclear. We examined associations of cardiometabolic risk score (CRS) and individual cardiometabolic risk factors with HRV variables in 6- to 8-year-olds. METHODS The participants were a population-based sample of 443 children participating in baseline measurements of the Physical Activity and Nutrition in Children trial. Cardiometabolic risk factors included waist circumference (WC), insulin, glucose, triglycerides, HDL cholesterol, systolic blood pressure (SBP), and diastolic blood pressure (DBP). CRS was calculated as WC + insulin + glucose + triglycerides - HDL cholesterol + the mea…

Blood GlucoseMalemedicine.medical_specialtyWaistEndocrinology Diabetes and Metabolismmedicine.medical_treatmentPopulationBlood Pressurechemistry.chemical_compoundHeart RateInternal medicineotorhinolaryngologic diseasesInternal MedicinemedicineHumansInsulinHeart rate variabilityChildeducationeducation.field_of_studyCholesterolbusiness.industryInsulinCardiometabolic Risk FactorsCardiorespiratory fitnessmedicine.diseaseCross-Sectional StudiesBlood pressurechemistryPediatrics Perinatology and Child HealthCardiologyFemaleMetabolic syndromebusinesscirculatory and respiratory physiologyPediatric Diabetes
researchProduct

Effects of Strength Training and Reduced Training on Functional Performance and Metabolic Health Indicators in Middle-Aged Men

2007

Changes in muscular fitness and metabolic health indicators were examined in 22 men (57.9 +/- 6.6 years, BMI 24.5 +/- 2.6 kg/m (2)) and 21 control men (58.2 +/- 6.1 years, BMI 25.4 +/- 2.8 kg/m (2)) during two consecutive 21-week periods: 1) whole body progressive strength training (ST: twice a week), and 2) continued reduced training (CRT: 3 ST sessions/2 weeks, n = 17 + 17). After the 21-week ST period, maximal strength of leg extensors increased in the ST group by 19.6 +/- 7.6 % vs. 2.8 +/- 4.4 % (p < 0.001) and also 10-m walking time and 10-step stair-climbing time shortened by - 17.2 +/- 7.6 % vs. 4.1 +/- 3.9 % (p < 0.01) and by - 8.2 +/- 6.8 % vs. - 3.0 +/- 6.8 % (p < 0.05) compared t…

Blood GlucoseMalemedicine.medical_specialtyWeight LiftingStrength trainingHealth StatusLipoproteinsPhysical fitnessDiastoleBlood sugarHemodynamicsBlood PressurePhysical Therapy Sports Therapy and RehabilitationAnimal scienceHumansMedicineOrthopedics and Sports MedicineFinlandMetabolic healthbusiness.industryFeeding BehaviorMiddle AgedSurgeryBlood pressurePhysical FitnessMuscle strengthbusinessInternational Journal of Sports Medicine
researchProduct

Blood pressure and cardiac autonomic nervous system in obese type 2 diabetic patients: effect of metformin administration

2004

Background: Hyperinsulinemia/insulin resistance and elevated plasma free fatty acids (FFA) levels are involved in the hypertension and cardiac sympathetic overactivity. Metformin improves insulin action and lower plasma FFA concentrations. We investigate the possible effect of metformin on arterial blood pressure (BP) and cardiac sympathetic nervous system. Methods: One hundred twenty overweight type 2 diabetic patients were treated by placebo (n = 60) + diet or metformin (850 mg twice daily) (n = 60) + diet for 4 months, to evaluate the effect of metformin treatment on the cardiac autonomic nervous system. Insulin resistance was measured by the Homeostasis Model Assessment (HOMA) index. He…

Blood GlucoseMalemedicine.medical_specialtyendocrine system diseasesmedicine.medical_treatmentBlood PressureType 2 diabetesFatty Acids NonesterifiedAutonomic Nervous SystemInsulin resistanceHeart RateDiabetes mellitusInternal medicineInternal MedicineHyperinsulinemiaDiabetes MellitusMedicineHumansHypoglycemic AgentsObesityHeart rate variabilityTriglyceridesAgedGlycated HemoglobinFree fatty acidAnthropometrybusiness.industryInsulinnutritional and metabolic diseasesInsulin resistanceMiddle Agedmedicine.diseaseMetforminMetforminEndocrinologyBlood pressureTreatment OutcomeDiabetes Mellitus Type 2Multivariate AnalysisFemalebusinessHyperinsulinismBiomarkersmedicine.drug
researchProduct

Prevalence of type 2 diabetes among patients with hypertension under the care of 30 Italian clinics of hypertension: results of the (Iper)tensione an…

2008

BACKGROUND AND PURPOSE Hypertension is known to be highly prevalent among patients with diabetes and associated with an increased risk of cardiovascular damage. In contrast, relatively few investigations have addressed the prevalence of diabetes among patients with hypertension. The purpose of the present study was to examine the prevalence of type 2 diabetes, the effectiveness of hypertension and diabetes control and the association with other cardiovascular risk factors and previous cardiovascular diseases in a cohort of patients with hypertension referred to 30 hospital outpatient clinics for the treatment of hypertension. METHODS AND PATIENTS Patients were considered as having diabetes …

Blood GlucoseMalemedicine.medical_specialtyhypertensionPhysiologyBlood Pressurediabetes; hypertension; prevalenceType 2 diabetesAmbulatory Care FacilitiesCohort Studieschemistry.chemical_compoundRisk FactorsInternal medicineDiabetes mellitusPrevalenceInternal MedicinemedicineHumansOutpatient clinicAgedCreatinineGlucose tolerance testDiabete di tipo 2 ipertensione arteriosamedicine.diagnostic_testdiabetesbusiness.industryGlucose Tolerance TestMiddle Agedmedicine.diseasediabetes; hypertensionBlood pressureEndocrinologyDiabetes Mellitus Type 2ItalychemistryFemaleMicroalbuminuriaCardiology and Cardiovascular MedicinebusinessCohort study
researchProduct

The changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: a new pharmacodynamic marker?

2015

Background: Everolimus is a mammalian target of rapamycin (mTOR) inhibitor approved for the treatment of metastatic renal cell carcinoma (mRCC). We aimed to assess the association between the baseline values and treatmentrelated modifications of total serum cholesterol (C), triglycerides (T), body mass index (BMI), fasting blood glucose level (FBG) and blood pressure (BP) levels and the outcome of patients treated with everolimus for mRCC. Methods: 177 patients were included in this retrospective analysis. Time to progression (TTP), clinical benefit (CB) and overall survival (OS) were evaluated. Results: Basal BMI was significantly higher in patients who experienced a CB (p=0,0145). C, T an…

Blood Glucoselcsh:MedicineBlood Pressureurologic and male genital diseasesTriglycerideBody Mass IndexAntineoplastic Agentchemistry.chemical_compoundRetrospective StudieRenal cell carcinomalcsh:ScienceMultidisciplinaryKidney NeoplasmKidney NeoplasmsSurvival RateEverolimuCholesterolDisease ProgressionHumanmedicine.drugResearch ArticleAdultmedicine.medical_specialtyAdolescentUrologyBlood sugarAntineoplastic AgentsYoung AdultInternal medicinemedicineCarcinomaHumansEverolimusCarcinoma Renal CellTriglyceridesNeoplasm StagingRetrospective StudiesBiochemistry Genetics and Molecular Biology (all)EverolimusCholesterolbusiness.industrylcsh:RCarcinomaRenal CellAdolescent; Adult; Antineoplastic Agents; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; Carcinoma Renal Cell; Cholesterol; Disease Progression; Everolimus; Humans; Kidney Neoplasms; Lipid Metabolism; Neoplasm Staging; Retrospective Studies; Survival Rate; Triglycerides; Young Adult; Biochemistry Genetics and Molecular Biology (all); Agricultural and Biological Sciences (all)Lipid metabolismBiomarkermedicine.diseaseLipid Metabolismrenal; carcinomaBlood pressureEndocrinologyAgricultural and Biological Sciences (all)chemistryPharmacodynamicslcsh:QbusinessBiomarkersPloS one
researchProduct